696 related articles for article (PubMed ID: 17437993)
21. A model for transmission of the H3K27me3 epigenetic mark.
Hansen KH; Bracken AP; Pasini D; Dietrich N; Gehani SS; Monrad A; Rappsilber J; Lerdrup M; Helin K
Nat Cell Biol; 2008 Nov; 10(11):1291-300. PubMed ID: 18931660
[TBL] [Abstract][Full Text] [Related]
22. Chromatin remodeling by the histone methyltransferase EZH2 drives lung pre-malignancy and is a target for cancer prevention.
Tellez CS; Picchi MA; Juri D; Do K; Desai DH; Amin SG; Hutt JA; Filipczak PT; Belinsky SA
Clin Epigenetics; 2021 Feb; 13(1):44. PubMed ID: 33632299
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic alterations of the keratin 13 gene in oral squamous cell carcinoma.
Naganuma K; Hatta M; Ikebe T; Yamazaki J
BMC Cancer; 2014 Dec; 14():988. PubMed ID: 25527207
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer.
Chen H; Tu SW; Hsieh JT
J Biol Chem; 2005 Jun; 280(23):22437-44. PubMed ID: 15817459
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer cells.
Benoit YD; Laursen KB; Witherspoon MS; Lipkin SM; Gudas LJ
J Cell Physiol; 2013 Apr; 228(4):764-72. PubMed ID: 23001792
[TBL] [Abstract][Full Text] [Related]
26. Anti-leukemic effects of HDACi Belinostat and HMTi 3-Deazaneplanocin A on human acute promyelocytic leukemia cells.
Valiulienė G; Stirblytė I; Jasnauskaitė M; Borutinskaitė V; Navakauskienė R
Eur J Pharmacol; 2017 Mar; 799():143-153. PubMed ID: 28192098
[TBL] [Abstract][Full Text] [Related]
27. 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.
Ni J; Hou X; Wang X; Shi Y; Xu L; Zheng X; Liu N; Qiu A; Zhuang S
Cell Death Dis; 2019 May; 10(5):355. PubMed ID: 31043583
[TBL] [Abstract][Full Text] [Related]
28. The Antitumoral Effect of the S-Adenosylhomocysteine Hydrolase Inhibitor, 3-Deazaneplanocin A, is Independent of EZH2 but is Correlated with EGFR Downregulation in Chondrosarcomas.
Aury-Landas J; Girard N; Lhuissier E; Adouane D; Delépée R; Boumediene K; Baugé C
Cell Physiol Biochem; 2019; 53(4):731-745. PubMed ID: 31613064
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
[TBL] [Abstract][Full Text] [Related]
30. 3-Deazaneplanocin A (DZNep), an inhibitor of the histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells.
Girard N; Bazille C; Lhuissier E; Benateau H; Llombart-Bosch A; Boumediene K; Bauge C
PLoS One; 2014; 9(5):e98176. PubMed ID: 24852755
[TBL] [Abstract][Full Text] [Related]
31. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation.
Gannon OM; Merida de Long L; Endo-Munoz L; Hazar-Rethinam M; Saunders NA
Clin Cancer Res; 2013 Jan; 19(2):428-41. PubMed ID: 23186778
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis.
Gupta RA; Shah N; Wang KC; Kim J; Horlings HM; Wong DJ; Tsai MC; Hung T; Argani P; Rinn JL; Wang Y; Brzoska P; Kong B; Li R; West RB; van de Vijver MJ; Sukumar S; Chang HY
Nature; 2010 Apr; 464(7291):1071-6. PubMed ID: 20393566
[TBL] [Abstract][Full Text] [Related]
33. 3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells.
Chiba T; Suzuki E; Negishi M; Saraya A; Miyagi S; Konuma T; Tanaka S; Tada M; Kanai F; Imazeki F; Iwama A; Yokosuka O
Int J Cancer; 2012 Jun; 130(11):2557-67. PubMed ID: 21717453
[TBL] [Abstract][Full Text] [Related]
34. 3-Deazaneplanocin A is a promising therapeutic agent for ovarian cancer cells.
Shen L; Cui J; Pang YX; Ma YH; Liu PS
Asian Pac J Cancer Prev; 2013; 14(5):2915-8. PubMed ID: 23803053
[TBL] [Abstract][Full Text] [Related]
35. Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells.
Takashina T; Kinoshita I; Kikuchi J; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Nishimura M; Dosaka-Akita H
Cancer Sci; 2016 Jul; 107(7):955-62. PubMed ID: 27116120
[TBL] [Abstract][Full Text] [Related]
36. PRIMA-1, a mutant p53 reactivator, restores the sensitivity of TP53 mutant-type thyroid cancer cells to the histone methylation inhibitor 3-Deazaneplanocin A.
Cui B; Yang Q; Guan H; Shi B; Hou P; Ji M
J Clin Endocrinol Metab; 2014 Jun; 99(6):E962-70. PubMed ID: 24512488
[TBL] [Abstract][Full Text] [Related]
37. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains.
Ku M; Koche RP; Rheinbay E; Mendenhall EM; Endoh M; Mikkelsen TS; Presser A; Nusbaum C; Xie X; Chi AS; Adli M; Kasif S; Ptaszek LM; Cowan CA; Lander ES; Koseki H; Bernstein BE
PLoS Genet; 2008 Oct; 4(10):e1000242. PubMed ID: 18974828
[TBL] [Abstract][Full Text] [Related]
38. 16-hydroxycleroda-3,13-dien-15,16-olide regulates the expression of histone-modifying enzymes PRC2 complex and induces apoptosis in CML K562 cells.
Lin YH; Lee CC; Chang FR; Chang WH; Wu YC; Chang JG
Life Sci; 2011 Dec; 89(23-24):886-95. PubMed ID: 21983300
[TBL] [Abstract][Full Text] [Related]
39. Elevated expression of a pharmacologic Polycomb signature predicts poor prognosis in gastric and breast cancer.
Clermont PL; Fornaro L; Crea F
Epigenomics; 2017 Oct; 9(10):1329-1335. PubMed ID: 28875726
[TBL] [Abstract][Full Text] [Related]
40. Polycomb group protein-associated chromatin is reproduced in post-mitotic G1 phase and is required for S phase progression.
Aoto T; Saitoh N; Sakamoto Y; Watanabe S; Nakao M
J Biol Chem; 2008 Jul; 283(27):18905-15. PubMed ID: 18453536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
